Related references
Note: Only part of the references are listed.Role of Fatty Acid Binding Protein 4 (FABP4) in Kidney Disease
Min Shi et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Relationship between retinal blood flow and cytokines in central retinal vein occlusion
Hidetaka Noma et al.
BMC OPHTHALMOLOGY (2020)
Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases
Masato Furuhashi
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2019)
Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors
Peige Song et al.
JOURNAL OF GLOBAL HEALTH (2019)
Optical coherence tomography of retinal and choroidal layers in patients with familial hypercholesterolaemia treated with lipoprotein apheresis
Claudia Stefanutti et al.
ATHEROSCLEROSIS SUPPLEMENTS (2019)
Independent links between plasma xanthine oxidoreductase activity and levels of adipokines
Masato Furuhashi et al.
JOURNAL OF DIABETES INVESTIGATION (2019)
Persistent metamorphopsia associated with branch retinal vein occlusion
Rie Osaka et al.
PLOS ONE (2018)
Role of the fatty acid-binding protein 4 in heart failure and cardiovascular disease
Ricardo Rodriguez-Calvo et al.
JOURNAL OF ENDOCRINOLOGY (2017)
Sustained Benefits of Ranibizumab with or without Laser in Branch Retinal Vein Occlusion
Ramin Tadayoni et al.
OPHTHALMOLOGY (2017)
Comparison between early or late intravitreal injection of dexamethasone implant in branch (BRVO) or central (CRVO) retinal vein occlusion: six-months follow-up
Fernanda Pacella et al.
CUTANEOUS AND OCULAR TOXICOLOGY (2017)
Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion 52-Week Results of the VIBRANT Study
W. Lloyd Clark et al.
OPHTHALMOLOGY (2016)
Metamorphopsia Associated with Branch Retinal Vein Occlusion
Koichiro Manabe et al.
PLOS ONE (2016)
Quantifying metamorphopsia in patients with diabetic macular oedema and other macular abnormalities
Asaf Achiron et al.
ACTA OPHTHALMOLOGICA (2015)
Angiotensin II receptor blockers decrease serum concentration of fatty acid-binding protein 4 in patients with hypertension
Masato Furuhashi et al.
HYPERTENSION RESEARCH (2015)
Reduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitus
Masato Furuhashi et al.
JOURNAL OF LIPID RESEARCH (2015)
Metabolic functions of FABPs-mechanisms and therapeutic implications
Goekhan S. Hotamisligil et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
RETINAL BLOOD FLOW CORRELATES TO AQUEOUS VASCULAR ENDOTHELIAL GROWTH FACTOR IN CENTRAL RETINAL VEIN OCCLUSION
Yoshihisa Yamada et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2015)
Ocular diseases and 10-year mortality: The Beijing Eye Study 2001/2011
Ya Xing Wang et al.
ACTA OPHTHALMOLOGICA (2014)
Mortality in Patients with Central Retinal Vein Occlusion
Mette Bertelsen et al.
OPHTHALMOLOGY (2014)
Retinal pigment epithelium, age-related macular degeneration and neurotrophic keratouveitis
Enrica Bianchi et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2013)
Circulating Levels of Fatty Acid-Binding Protein Family and Metabolic Phenotype in the General Population
Shutaro Ishimura et al.
PLOS ONE (2013)
Elevation of Fatty Acid-Binding Protein 4 Is Predisposed by Family History of Hypertension and Contributes to Blood Pressure Elevation
Hideki Ota et al.
AMERICAN JOURNAL OF HYPERTENSION (2012)
Endothelial cell-fatty acid binding protein 4 promotes angiogenesis: role of stem cell factor/c-kit pathway
Harun Elmasri et al.
ANGIOGENESIS (2012)
Use of laser speckle flowgraphy in ocular blood flow research
Tetsuya Sugiyama et al.
ACTA OPHTHALMOLOGICA (2010)
Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion Six-Month Primary End Point Results of a Phase III Study
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2010)
The Prevalence of Retinal Vein Occlusion: Pooled Data from Population Studies from the United States, Europe, Asia, and Australia
Sophie Rogers et al.
OPHTHALMOLOGY (2010)
Macular microcirculation in hypertensive patients with and without branch retinal vein occlusion
Hidetaka Noma et al.
ACTA OPHTHALMOLOGICA (2009)
Macular microcirculation and macular oedema in branch retinal vein occlusion
H. Noma et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2009)
Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells
Harun Elmasri et al.
FASEB JOURNAL (2009)
Major Eye Diseases and Risk Factors Associated with Systemic Hypertension in an Adult Chinese Population The Beijing Eye Study
Shuang Wang et al.
OPHTHALMOLOGY (2009)
Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes
Anna Cabre et al.
JOURNAL OF LIPID RESEARCH (2008)
Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets
Masato Furuhashi et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Central retinal vein occlusion case-control study
Hideki Koizumi et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis
D. C. Y. Yeung et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome
AM Xu et al.
CLINICAL CHEMISTRY (2006)
Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6
H Noma et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2005)
Effect of arteriovenous sheathotomy on retinal blood flow and macular edema in patients with branch retinal vein occlusion
N Horio et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2005)
Evaluation of arteriovenous crossing sheathotomy for branch retinal vein occlusion by fluorescein videoangiography and image analysis
H Yamaji et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2004)
Share Paper
